Difference between revisions of "OncoMouse"
Caseorganic (Talk | contribs) |
Caseorganic (Talk | contribs) |
||
| Line 1: | Line 1: | ||
| + | [[Image:oncomouse.jpg|600px|right]] | ||
| + | |||
===Definition=== | ===Definition=== | ||
| − | OncoMouse is the first patented animal | + | OncoMouse is the first patented animal and animal cyborg. Oncomouse was engineered with a pump attached to its body in order to understand how to manage human life in long term space travel. Klines and Cline had a quite Positive view on the ideas of the future of space travel. Humans, space, drugs. Environment To surmount the everyday conditions of reality in order to ameliorate the symptoms of everyday reality.<ref>Gray, Chris Hables, ed. The Cyborg Handbook. New York: Routledge, 1995.</ref> |
| − | + | ||
| − | Oncomouse was engineered with a pump attached to its body in order to understand how to manage human life in long term space travel. | + | |
| − | + | ||
| − | Klines and Cline had a quite Positive view on the ideas of the future of space travel | + | |
| − | Humans, space, drugs. Environment | + | |
| − | To surmount the everyday conditions of reality in order to ameliorate the symptoms of everyday reality | + | |
| − | + | ||
| − | + | ||
Two separate patents were issued to Harvard College covering methods for providing a cell culture from a transgenic non-human animal (U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene (U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016). | Two separate patents were issued to Harvard College covering methods for providing a cell culture from a transgenic non-human animal (U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene (U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016). | ||
| − | A | + | The OncoMouse is a mouse with a pump attached to it that can administer OncoMouse is a term used to describe (a type of laboratory mouse that has been genetically modified using modifications designed by Philip Leder and Timothy A Stewart<ref>European Patent Register entry for European patent no. 0169672, under "Inventor(s)". Consulted on February 22, 2008.</ref> of Harvard University to carry a specific gene called an activated oncogene. The activated oncogene significantly increases the mouse’s susceptibility to cancer, and thus makes the mouse suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.<ref>Trademark: USPTO serial number 75797027</ref>) http://en.wikipedia.org/wiki/Oncomouse |
==References== | ==References== | ||
| Line 18: | Line 12: | ||
[[Category:Book Pages]] | [[Category:Book Pages]] | ||
| − | [[Category: | + | [[Category:Marked for Editing]] |
Revision as of 02:33, 6 November 2011
Definition
OncoMouse is the first patented animal and animal cyborg. Oncomouse was engineered with a pump attached to its body in order to understand how to manage human life in long term space travel. Klines and Cline had a quite Positive view on the ideas of the future of space travel. Humans, space, drugs. Environment To surmount the everyday conditions of reality in order to ameliorate the symptoms of everyday reality.[1]
Two separate patents were issued to Harvard College covering methods for providing a cell culture from a transgenic non-human animal (U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene (U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016).
The OncoMouse is a mouse with a pump attached to it that can administer OncoMouse is a term used to describe (a type of laboratory mouse that has been genetically modified using modifications designed by Philip Leder and Timothy A Stewart[2] of Harvard University to carry a specific gene called an activated oncogene. The activated oncogene significantly increases the mouse’s susceptibility to cancer, and thus makes the mouse suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.[3]) http://en.wikipedia.org/wiki/Oncomouse
